migraine...lisbon lies in the western iberian peninsula on the atlantic ocean and the river tagus....

International Forumon

Migraine

Migraine2020

Theme: “It’s not just aHeadache”

March 09-10, 2020 Lisbon, Portugal

Migraine2020

Invitation

About Conference

Cenetri Publishing Group takes keen delectation and highly regarded to host a Captivating Scientific meeting “International Forum on Migraine”. The Conference highlights the theme “It’s not just a Headache” March 09-10, 2020 Lisbon, Portugal. International Forum on Migraine presents a unique occasion to meet prominent Directors, Neurologist, Neurosurgeons, Doctors, Academician, scientists and specialists across the globe and listen to best speakers on new expansions that will influence and spread the future of Migraine Disorders. The conference will unite the endeavors made all over the world to spread the field of Health through speakers and suppliers who are recognized world leaders in this area of specialization.

Cenetri Conferences organizing the Migraine 2020 which is going to be held from March 09-10, 2020 in Lisbon, Portugal focusing on cur-rent and future advancements in Migraine. The theme of this year’s meeting is “It’s not just a Headache”, which will provide an international platform for discussion and sharing of novel ideas for present and future expansions in treatment of Migraine.

March 09-10, 2020Lisbon, Portugal

www.migraineconferences.org

Migraine2020

Sessions

• Migraine• Pathophysiology of Migraine• Aura• Diagnostic Criteria for migraine without Aura• Confusional migraine• Hemiplegic migraine• Prophylaxis• Cluster Headache• Tension Headache• Chronic Paroxysmal hemicranias• Cervicogenic Headache• Occipital Neuralgia• Analgesic Headache• Idiopathic Stabbing Headache• Miscellaneous Headache• Analgesic-rebound headache• Aneurysm• Anticonvulsant• Antidepressant• Arnold-Chiari deformity• Hormone headache• Hydrocephalus



Migraine2020

Market Analysis


The global migraine drugs market size is expected to be valued at USD 7.8 billion by 2025, as per a new report by Grand View Research, Inc., exhibiting an 18.0% CAGR during the forecast period. The market is largely driven by factors such as rise in disease prevalence, development of novel therapies, lifestyle changes, and hormonal medications.

Migraine is a debilitating neurological disease characterized by recurrent attacks of severe throbbing head pain that can last for more than three days. Migraine pain may get worse on movement, preventing the patient from carrying out normal, day-to-day activities. In about one-third of attacks, both sides of the head, face, or neck are affected.

Over the past five years, the global migraine drugs market has been relatively stagnant, with the market mainly dominated by usage of generic triptans and other off-label drugs. Majority of the currently prescribed drugs for both acute and preventative treatment are associated with poor efficacy and an unfavorable side-effect profile.

Launch of Amgen/ Novartis’ CGRP mAb Aimovig and Teva Pharma’s Ajovy is the first step toward revolutionizing the treatment paradigm of migraine prevention. For drug manufacturers likely to enter the market by 2019, such as Eli Lilly, Alder BioPharma, and Biohaven Pharma, pricing will be a key differentiating factor as all CGRP-based therapies have a similar efficacy and safety profile.


Migraine2020



Migraine2020


Conference Highlights

Why to Attend

Target Audience

• 9+ Keynote Speakers• 30+ Plenary Speakers• 3+ Exhibitors• 14 Innovative Educational Sessions• B2B Meetings• Exhibition

• Meet Global Experts and Influencers Face to Face• Talks by Top Professors and Young researchers on Latest trends• Certification, Awards and Global Recognition to Researchers• Global Business and Networking Opportunities with Peers• Sterling Workshop sessions and Exhibition• Complementary Networking Tour to Explore Malaysia

• World Leading Experts• world’s top migraine and headache experts• Doctors• Specialists• Researchers• Scientists• Geneticists• Psychologists


Migraine2020


About Lisbon

Lisbon is the capital and the largest city of Portugal, with an estimated population of 505,526 within its administrative limits in an area of 100.05 km Its urban area extends beyond the city’s administrative limits with a population of around 2.8 million people, being the 11th-most populous urban area in the European Union. About 3 million people live in the Lisbon Metropolitan Area (which represents approximately 27% of the country’s population). It is mainland Europe’s westernmost capital city and the only one along the Atlantic coast. Lisbon lies in the western Iberian Peninsula on the Atlantic Ocean and the River Tagus. The westernmost areas of its metro area form the westernmost point of Continental Europe, which is known as Cabo da Roca, located in the Sintra Mountains.

Contact

Phaneendra R conference convenor [email protected]+1 (563) 447-3392, +1 (563) 447-2447


migraine...lisbon lies in the western iberian peninsula on the atlantic ocean and the river tagus....

Documents